Review
Open access
Oct 2026
Reasons for delay in receipt of neoadjuvant chemotherapy in patients with muscle invasive bladder cancer.
178 Background: Delay in time from muscle invasive bladder cancer (MIBC) diagnosis to neoadjuvant chemotherapy (NACT) > 60 days, can negatively impact cancer related outcomes. However, the underlying causes of these delays remain poorly characterized, underscoring the need for further investigation. Methods:...
Margaux Wooster, Abha Kulkarni, R. Raghunathan et al.
· JCO Oncology Practice · 0 citations